Correspondence 0001493152-22-033406 from Bon Natural Life Ltd (BON)
Bon Natural Life Ltd
Date: Nov. 22, 2022 · CIK: 0001816815 · Accession: 0001493152-22-033406
AI Filing Summary & Sentiment
File numbers found in text: 333-267116
Referenced dates: November 14, 2022
Show Raw Text
CORRESP
1
filename1.htm
Joe
Laxague
Partner
jlaxague@cronelawgroup.com
Mason
Allen
Of
Counsel
mallen@cronelawgroup.com
VIA
EDGAR
November
22, 2022
THE
UNITED STATES SECURITIES
AND
EXCHANGE COMMISSION
Washington,
D.C. 20549
Attn:
Abby
Adams
Re:
Bon
Natural Life Limited
Amendment
No. 2 to Registration Statement on Form F-3
Filed
October 31, 2022
File
No. 333-267116
Dear
Ms. Adams:
We
write on behalf of Bon Natural Life Limited (the “Company”) in response to comments by the United States Securities and Exchange
Commission (the “Commission”) in its letter dated November 14, 2022, commenting on the Company’s Amended Registration
Statement on Form F-3 filed October 31, 2022 (the “Registration Statement”).
Titling
and paragraph numbering of the comments listed below corresponds to the titling and numbering used in the Commission’s comment
letter.
Amendment
No. 2 to Registration Statement on Form F-3
Cover
Page
1.
Revise the cover page to disclose the information set forth in the last sentence of your supplemental response to comment 1 and
cross-reference an explanation of the “Negative List.” Your disclosure should address how your operations fall outside
of the categories covered by the most recent edition of the Negative List, and any relevant guidelines or provisions that informed
your determination that the prohibition under the Negative List does not apply to your operations.
Response:
In response to this comment, the Company has amended the Registration Statement to include the information requested, to include a brief
explanation of why its business is not included in the most recent version of the Negative List, and to include a cross-reference to
the explanation of the Negative List included in its most recent annual report on Form 20-F.
Abby
Adams
United
States Securities and Exchange Commission
November
22, 2022
Page
2 of 2
2.
We acknowledge your response to prior comment 3. However, we note that the crossreference remains in brackets and it is unclear how
the referenced disclosure in the Form 20-F relates to the prospectus disclosure in the document regarding the intercompany transfer.
Please revise accordingly.
Response:
In response to this comment, the Company has amended the Registration Statement to clarify the reference and add additional specificity.
The brackets, which were intended as parentheticals, have been removed.
Please
feel free to contact me should you require additional information at (775) 234-5221 or jlaxague@cronelawgroup.com.
THE
CRONE LAW GROUP, P.C.
By:
/s/
Joe Laxague
Joe
Laxague, Esq.